Education
About Us
Working with TipRanks
Follow Us
Health Catalyst (HCAT)
NASDAQ:HCAT
HCAT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.52 - $9.24
Previous CloseN/A
Volume315.36K
Average Volume (3M)714.04K
Market Cap
$205.49M
Enterprise Value$337.94M
Total Cash (Recent Filing)$97.34M
Total Debt (Recent Filing)$172.79M
Price to Earnings (P/E)―
Beta1.37
Next Earnings
Nov 11, 2025EPS Estimate
0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.04
Shares Outstanding70,373,630
10 Day Avg. Volume1,243,907
30 Day Avg. Volume714,036
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.64
Enterprise Value/Revenue1.07
Enterprise Value/Gross Profit2.36
Enterprise Value/Ebitda-9.51
Forecast
1Y Price Target
$4.79Price Target Upside59.67% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
Bulls Say, Bears Say
Bulls Say
Cost ManagementAnnounced restructuring valued at $40MM+ with a 9% workforce reduction and contract restructuring expected to yield significant annualized savings.
Financial PerformanceHCAT has been able to sufficiently cut costs and integrate AI to improve adjusted EBITDA and cash flow.
ProfitabilityThe planned workforce reduction is expected to result in substantial annualized cost savings, helping to maintain EBITDA guidance.
Bears Say
Leadership ChangesCEO Dan Burton, the founder, will be stepping down, which has contributed to the stock pulling back significantly.
Market ChallengesThe hospital buying environment is expected to become more challenging due to the Big Beautiful Bill Act, affecting future growth prospects.
Revenue OutlookThe 2025 revenue guide is lowered to ~$310MM from a previous ~$335MM.
Health Catalyst News
HCAT FAQ
What was Health Catalyst’s price range in the past 12 months?
Health Catalyst lowest stock price was $2.52 and its highest was $9.24 in the past 12 months.
What is Health Catalyst’s market cap?
Health Catalyst’s market cap is $205.49M.
When is Health Catalyst’s upcoming earnings report date?
Health Catalyst’s upcoming earnings report date is Nov 11, 2025 which is in 83 days.
How were Health Catalyst’s earnings last quarter?
Health Catalyst released its earnings results on Aug 07, 2025. The company reported $0.04 earnings per share for the quarter, beating the consensus estimate of $0.033 by $0.007.
Is Health Catalyst overvalued?
According to Wall Street analysts Health Catalyst’s price is currently Undervalued.
Does Health Catalyst pay dividends?
Health Catalyst does not currently pay dividends.
What is Health Catalyst’s EPS estimate?
Health Catalyst’s EPS estimate is 0.07.
How many shares outstanding does Health Catalyst have?
Health Catalyst has 70,373,630 shares outstanding.
What happened to Health Catalyst’s price movement after its last earnings report?
Health Catalyst reported an EPS of $0.04 in its last earnings report, beating expectations of $0.033. Following the earnings report the stock price went down -23.306%.
Which hedge fund is a major shareholder of Health Catalyst?
Currently, no hedge funds are holding shares in HCAT
Health Catalyst Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.79 (59.67% Upside)
$4.79 (59.67% Upside)
Blogger Sentiment
Bullish
HCAT Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 143.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 5.4%
Last 30 Days ▲ 2.9%
Last 30 Days ▲ 2.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-55.58%
12-Months-Change
Fundamentals
Return on Equity
-28.42%
Trailing 12-Months
Asset Growth
-10.92%
Trailing 12-Months
Company Description
Health Catalyst
Health Catalyst (HCAT) is a leading provider of data and analytics technology and services for healthcare organizations. The company specializes in delivering solutions that enhance clinical, operational, and financial outcomes for healthcare providers and payers. Health Catalyst's core offerings include a data operating system, analytics applications, and consulting services designed to help clients leverage data to drive performance improvement and strategic decision-making in the healthcare sector.
HCAT Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects a mix of positive performance metrics and strategic initiatives aimed at improving profitability, alongside significant challenges due to macroeconomic factors and funding cuts impacting revenue growth and client contracts.View all HCAT earnings summariesHCAT Stock 12 Month Forecast
Average Price Target
$4.79
▲(59.67% Upside)
Technical Analysis
HealthStream
―
OptimizeRx
―
Evolent Health
―
SOPHiA GENETICS
―
Definitive Healthcare Corp
―
Ownership Overview
4.60% Insiders
19.82% Mutual Funds
44.22% Other Institutional Investors
19.05% Public Companies and
Individual Investors